Cutler Group’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-200
Closed -$11K 5932
2021
Q4
$11K Buy
+200
New +$10.1K ﹤0.01% 3633
2020
Q4
Sell
-2,400
Closed -$78K 5405
2020
Q3
$78K Buy
2,400
+2,000
+500% +$64.3K ﹤0.01% 1486
2020
Q2
$11K Sell
400
-5,976
-94% -$169K ﹤0.01% 2819
2020
Q1
$144K Buy
+6,376
New +$183K 0.01% 1143
2019
Q3
Sell
-376
Closed -$9.56K 4604
2019
Q2
$9K Buy
+376
New +$9.33K ﹤0.01% 2766
2019
Q1
Sell
-1,216
Closed -$30.7K 4656
2018
Q4
$27K Buy
+1,216
New +$31.2K ﹤0.01% 1905
2018
Q2
Sell
-16
Closed 4766
2018
Q1
$0 Sell
16
-1,984
-99% -$46.1K ﹤0.01% 5099
2017
Q4
$44K Buy
2,000
+1,600
+400% +$34.8K ﹤0.01% 1966
2017
Q3
$8K Buy
+400
New +$8.2K ﹤0.01% 4017
2017
Q1
Sell
-2,000
Closed -$30K 7086
2016
Q4
$30K Hold
2,000
﹤0.01% 3061
2016
Q3
$32K Buy
+2,000
New +$33.7K ﹤0.01% 2934

Other funds holding RXL

Cutler Group's RXL Position: Q1 2022 in Review

Cutler Group sold out of ProShares Ultra Health Care (RXL) in Q1 2022, closing a stake of 200 shares — an estimated $11K sold.

Cutler Group first reported a position in RXL in Q3 2016 and held it in 11 quarters. The position peaked at $144K in Q1 2020. 22 funds tracked by Wall St. Rank hold RXL as of Q1 2022.

  • Cutler Group reported no remaining ProShares Ultra Health Care position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 200 ProShares Ultra Health Care shares in Q1 2022, an estimated $11K.
  • Cutler Group first reported a position in ProShares Ultra Health Care in Q3 2016 and held it in 11 quarters.
  • Cutler Group's ProShares Ultra Health Care position peaked at $144K in Q1 2020.
  • 22 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.